Related Experiment Video
Updated: May 30, 2025
Reverse Total Shoulder Arthroplasty
Published on: July 5, 2011
Tranexamic acid use in rotator cuff repair: A systematic review of perioperative outcomes
Neil Jain1, Jonathan McKeeman1, Kyle Schultz2
1Department of Orthopaedic Surgery, St. Luke's University Health Network, Bethlehem, PA, USA.
Background:
Tranexamic acid (TXA) use has become the gold standard in total joint arthroplasty to limit intraoperative blood loss and transfusion rates. More recently, the indications for TXA have expanded to knee and shoulder arthroscopy with promising early results. However, the effectiveness of TXA during arthroscopic rotator cuff repair (RCR) is unclear. Therefore, the purpose of this study was to investigate perioperative outcomes following the use of TXA during RCR.
Methods:
A systematic review was performed via the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using PubMed, MEDLINE, Embase, and Cochrane databases in November 2024. Studies were assessed for quality of visual clarity, operative time, mean arterial pressure (MAP), volume of arthroscopy irrigation used, arthroscopic pump pressure, and clinical outcomes.
Results:
A total of 12 clinical trials involving 999 patients were included. 9 studies reported on visual clarity and 6 of these reported improvements in visual clarity with TXA administration. Four studies reported improvements in postoperative pain, however outcomes varied greatly depending on when follow-up assessment occurred. A majority of studies did not report differences in operative time, irrigation volume, or postoperative swelling. There were no venous thromboembolism events reported in the included studies.
Conclusion:
TXA dosing during RCR surgery may improve visual clarity, however its effect on other perioperative outcomes remains unclear.
Level Of Evidence:
Level I.
